Chronic Infection Triggers a Sustained GC Response with Prolonged Plasma Cell and Memory B Cell Output
(A) We infected AIDrep mice with rARM or rCl13 on day 0, followed by TAM administration on day 0 and day 5 (early), day 10 and day 15 (intermediate), or day 30 and day 35 (late), respectively.
(B) EYFP-expressing cells were analyzed 2 months after infection. Representative FACS plots are gated on EYFP+ cells (see Figure S3). Numbers in FACS plots indicate percentages of gated cells among EYFP+ cells.
(C–E) EYFP-expressing GC B cells (C), MemB cells (D), and ASCs (E) in the spleen were enumerated. Dotted lines indicate background levels of EYFP-expressing cells in uninfected control mice.
(F) Representative histological spleen sections from rCl13- and ARM-infected mice in the early labeled group.
Magnification bar: 50 μm. Bars represent means ± SEM, n = 4–5 (C–E) and n = 6 from three datasets (F). N = 2. Two-way ANOVA with Bonferroni’s post-test for multiple comparisons. ∗p < 0.05, ∗∗p < 0.01. See also Figure S3.